Dealing With The Disease Of Colon Carcinoma

Posted by Jason Bishop

February 8, 2010

One of the more aggressive and worst types of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it is usually detected in its late stages when it is extremely hard to do anything about it.

As the effects of neuroendocrine colon cancer become visible only in the most advanced stages the survival rate drops at an alarming rate. Existing tumours are malignant and are usually detected with distant metastases. Surveys show reports tell us that most of the cases of neuroendocrine cancer end in death.

Though the possibilities of neuroendocrine carcinoma in colon are rare at best if one is affected the patient's condition becomes much worse than patients who suffer from adenocarcinoma.

Research reveals that the end results of this form of cancer stay the same with age, sex or tumour location. However, neuroendocrine colon carcinoma will depend heavily on the tumour's stage. Standard cases have revealed that people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. On the other hand, in several cases, if the tumour is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.

It is unfortunate that medical science has developed no adequate methods to treat this kind of cancer. A more common technique that doctors regularly use is immunohistochemical staining methods. This method helps doctors with coping with the severity of the neuroendocrine colon cancer and helps to determine the best medication and a treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of the tumour with the antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient.

Neuroendocrine colon carcinoma is difficult to treat and a case study in which several patients suffered from colon carcinoma was examined, it was noted that the average survival rate related to this disease was approximately seven months. In the later stages these rates drop to less than five months. The great majority of these cases were initially detected as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery may not be a perfect or even viable treatment so surgery may not provide a satisfactory cure. Therefore it becomes necessary to make note of carcinoma as soon as possible and provide proper medication for it.

See us at Colon Carcinoma.

Colon Rectal Cancer